Dr. Ari Kellen leverages more than three decades of experience in the healthcare sector to advise early-stage companies that are building their own groundbreaking healthcare solutions. To this end, he invests in and serves as a strategic advisor to multiple firms based in the US, Israel, and Europe. During the last several years, Dr. Ari Kellen has served as a member of the board at Theraclion and Vaxil Bio Therapeutics. In addition, he advises BioNanoSim, a nanotechnology drug delivery firm, where he applies his healthcare knowledge to serve as a strategic advisor. Concurrently, Dr. Kellen works with Nouri Life and several other healthcare entities in a similar capacity.

Before undertaking his current endeavors, Dr. Kellen practiced medicine and supervised a large division at a hospital in South Africa. He is a graduate of the University of Witwatersrand in South Africa, where he studied both medicine and business, earning his MBBCh and MBA with distinction.